Invention Grant
- Patent Title: Crystalline forms of C21H22Cl2N4O2
-
Application No.: US16227820Application Date: 2018-12-20
-
Publication No.: US10738027B2Publication Date: 2020-08-11
- Inventor: Gary DeCrescenzo , Dean Welsch , Petinka I. Vlahova , Stephan X. M. Boerrigter , Alexander Aronov , Ali Keshavarz-Shokri , Alexander N. Scangas , Kathy Stavropoulos , Benjamin Littler , Irina Nikolaevna Kadiyala , Rossitza Gueorguieva Alargova
- Applicant: BIOMED VALLEY DISCOVERIES, INC. , VERTEX PHARMACEUTICALS INCORPORATED
- Applicant Address: US MO Kansas City US MA Boston
- Assignee: Biomed Valley Discoveries, Inc.,Vertex Pharmaceuticals Incorporated
- Current Assignee: Biomed Valley Discoveries, Inc.,Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MO Kansas City US MA Boston
- Agency: Bryan Cave Leighton Paisner LLP
- Main IPC: C07D401/04
- IPC: C07D401/04 ; A61K45/06 ; A61P35/00 ; A61K31/4439
Abstract:
The present invention provides crystalline forms of a compound of formula (I): Also provided are pharmaceutical compositions that include the provided crystalline forms and methods of using the provided crystalline forms and pharmaceutical compositions for the treatment of cancer.
Public/Granted literature
- US20190127348A1 CRYSTALLINE FORMS OF C21H22Cl2N4O2 Public/Granted day:2019-05-02
Information query
